Not the desired effect

prescription pad doctor
Restrictions on alprazolam prescribing have failed to curb usage, with sales of bigger packs on the increase  Measures introduced in 2017 to prevent potentially harmful usage of alprazolam have failed to impact on usage of the drug, new Australian research has revealed.  From February 1, 2017, the 2mg listing of alprazolam was delisted from the

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous SA cracks down on vaping
Next Who are the 14 most influential people in pharmacy?